Trauma Hemorrhagic Shock-Induced Lung Injury Involves a Gut-Lymph-Induced TLR4 Pathway in Mice by Reino, Diego C. et al.
Trauma Hemorrhagic Shock-Induced Lung Injury
Involves a Gut-Lymph-Induced TLR4 Pathway in Mice
Diego C. Reino
., Vadim Pisarenko
., David Palange, Danielle Doucet, Robert P. Bonitz, Qi Lu, Iriana
Colorado, Sharvil U. Sheth, Benjamin Chandler, Kolenkode B. Kannan, Madhuri Ramanathan, Da Zhong
Xu, Edwin A. Deitch*, Rena Feinman*
Department of Surgery, University of Medicine and Dentistry of New Jersey (UMDNJ)- New Jersey Medical School, Newark, New Jersey, United States of America
Abstract
Background: Injurious non-microbial factors released from the stressed gut during shocked states contribute to the
development of acute lung injury (ALI) and multiple organ dysfunction syndrome (MODS). Since Toll-like receptors (TLR) act
as sensors of tissue injury as well as microbial invasion and TLR4 signaling occurs in both sepsis and noninfectious models of
ischemia/reperfusion (I/R) injury, we hypothesized that factors in the intestinal mesenteric lymph after trauma hemorrhagic
shock (T/HS) mediate gut-induced lung injury via TLR4 activation.
Methods/Principal Findings: The concept that factors in T/HS lymph exiting the gut recreates ALI is evidenced by our
findings that the infusion of porcine lymph, collected from animals subjected to global T/HS injury, into naı ¨ve wildtype (WT)
mice induced lung injury. Using C3H/HeJ mice that harbor a TLR4 mutation, we found that TLR4 activation was necessary
for the development of T/HS porcine lymph-induced lung injury as determined by Evan’s blue dye (EBD) lung permeability
and myeloperoxidase (MPO) levels as well as the induction of the injurious pulmonary iNOS response. TRIF and Myd88
deficiency fully and partially attenuated T/HS lymph-induced increases in lung permeability respectively. Additional studies
in TLR2 deficient mice showed that TLR2 activation was not involved in the pathology of T/HS lymph-induced lung injury.
Lastly, the lymph samples were devoid of bacteria, endotoxin and bacterial DNA and passage of lymph through an
endotoxin removal column did not abrogate the ability of T/HS lymph to cause lung injury in naı ¨ve mice.
Conclusions/Significance: Our findings suggest that non-microbial factors in the intestinal mesenteric lymph after T/HS are
capable of recreating T/HS-induced lung injury via TLR4 activation.
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Introduction
Acute lung injury (ALI) and the development of the acute
respiratory distress syndrome (ARDS) is one of the major causes of
death in trauma patients and is associated with mortality rates as
high as 40% in intensive care unit patients [1]. The mortality rate
of ALI and ARDS has only modestly improved over the last
several decades, since the pathophysiology of this syndrome
remains incompletely understood and thus therapy remains largely
supportive. Consequently, extensive investigative efforts have been
focused on clarifying the basic biology of trauma hemorrhagic
shock (T/HS)-induced ALI and ARDS. This work has generated
several working hypotheses, one of which is that acute lung injury
after trauma-hemorrhage is secondary to factors released from the
stressed gut [1]. A key element in this gut hypothesis of ARDS is
that a splanchnic ischemia-reperfusion (I/R) insult leads to gut
inflammation and injury, which in turn results in a gut-induced
systemic inflammatory state as well as lung injury. Although gut
ischemia has been implicated in the development of ALI, the
mechanisms by which a gut I/R event leads to lung injury remains
to be fully clarified. Based on our studies showing that T/HS-
induced lung injury can be prevented in both rodents and non-
human primates by ligating the mesenteric lymph duct [2,3] and
that the injection of T/HS mesenteric lymph, collected from
animals subjected to T/HS, into naı ¨ve rodents recreates the lung
injury observed after actual T/HS [4], we have proposed the
hypothesis that gut-derived lymph is the vehicle by which gut
injury leads to distant organ injury [5]. The mechanisms by which
T/HS lymph is sensed in the lung and the signaling pathways that
are involved in T/HS lymph-induced inflammation and injury are
not well defined. Since T/HS lymph is sterile and does not contain
measurable levels of endotoxin [6], but does contain biologically
active non-microbial protein and lipid species [7,8] it appears that
T/HS mesenteric lymph-induced lung injury is being directly
mediated by gut-derived endogenous ligands.
Based on studies indicating that the germline-encoded pattern-
recognition Toll-like receptors (TLR) recognize molecular motifs
shared by large groups of microorganisms [9,10] as well as by
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[11,12], we hypothesized that T/HS lymph was exerting its lung
injurious effects via a TLR-dependent pathway. In this study, we
chose to focus on TLR4 as the putative signaling system by which
T/HS lymph induces lung injury for the following reasons. First,
TLR4 activation has been implicated in the pathogenesis of organ
injury, increased inflammatory gene expression, innate immune
system priming and microvascular dysfunction after hemorrhagic
shock as well as mechanical and thermal trauma [13,14,15,
16,17,18,19,20] . Secondly, TLRs are constitutively expressed
on cells of the innate immune system, including macrophages
and neutrophils [9]. Lastly, TLR4 has recently been documented
to recognize endogenous danger-type or ‘alarmin’ factors
thereby implicating TLR4 as a sensor of tissue injury as well as
microbial invasion [21]. Therefore, the goal of this study was to
determine whether non-microbial factors in the intestinal
mesenteric lymph after T/HS mediate gut-induced lung injury
via TLR4 activation.
Materials and Methods
Animals
Adult male non-castrated Yorkshire minipigs, weighing 25 to
35 kg were used in this study (Animal Biotech Industries). Male
10–12 week old outbred cesarean-derived (CD-1) mice, TLR4-
mutated (C3H/HeJ) mice and their wild-type (WT) littermates
(C3H/HeOuJ), TLR-2 deficient (TLR2
2/2) mice and their WT
(C57BL/6J) littermates, and C57BL/6J-Ticam1
Lps2/J and their
WT (C57BL/6J) littermates were obtained from The Jackson
Laboratory. Mice on the C57BL/6J background with a specific
deletion of the MyD88 gene (MyD88
2/2 mice) were kindly
provided by Dr. Samuel J. Leibovich (UMDNJ-New Jersey
Medical School, Newark, N.J). The genotyping of Myd88
2/2,
Myd88
+/2 and Myd88
+/+ WT (C57BL/6J) was described pre-
viously [22]. C3H/HeJ mice have a point mutation in the TLR4
gene [23] and C57BL/6J-Ticam1
Lps2/J mice have a Lps mutation
in the Trif/or Ticam-1 gene that inhibit TLR4- and TRIF-
dependent signaling respectively. From herein C3H/HeJ mice will
be referred to as TLR4
mut and C57BL/6J-Ticam1
Lps2/J mice will
be referred to as TRIF
mut mice. The animals were maintained in
accordance with the guidelines of the National Institutes of Health
Guide for Care and Use of Laboratory Animals and the
experiments were approved by the Animal Care and Use
Committee of the University of Medicine and Dentistry of New
Jersey.
Pig trauma-hemorrhagic shock and lymph collection
model
Pigs underwent mesenteric lymph duct cannulation, followed by
T/HS or trauma sham-shock (T/SS), as described previously [24].
Briefly, male pigs were subjected to T/HS which involved a
laparotomy with mesenteric lymph duct cannulation and with-
drawal of blood in a staged fashion to a MAP of 40 mm Hg. The
MAP was maintained until the base deficit reached -5 or the total
shock period reached 3 hours. Animals were then resuscitated in a
staged fashion to a MAP of 80–100 mm Hg. T/SS animals
underwent laparotomy with lymph duct cannulation and without
blood withdrawal. Mesenteric lymph was collected in sterile tubes
for 30 minutes before shock, during shock and on an hourly basis
during the postshock period. The collected lymph specimens were
centrifuged at 500 g for 20 minutes at 4uC to remove all cellular
components, tested for sterility on MacConkey and blood agar
plates, aliquoted and stored at 280uC.
T/HS model
Male mice were anesthetized with pentobarbital (60–80 mg/kg
IP) and under strict asepsis, a 2.5-cm midline laparotomy was
performed. Isoflurane was given if needed to maintain the surgical
level of anesthesia. Blood was withdrawn from the jugular vein
until a mean arterial pressure (MAP) between 35–40 mmHg was
obtained and maintained for 60 min. After 60 min, the mice were
resuscitated with their shed blood. Animals subjected to T/SS
underwent cannulation of the femoral artery and jugular vein
followed by a laparotomy; however, no blood was withdrawn and
the MAP was kept within normal limits. At 3 hr, after the end of
shock or sham shock period, the Evans blue dye (EBD) lung
permeability assay was performed.
Lymph infusion protocol
Mice underwent laparotomy as well as internal jugular vein
cannulation. Laparotomy was closed after 15 minutes using two
layers of 3–0 silk suture. WT, TLR4
mut, Myd88
2/2, TRIF
mut and
TLR2
2/2 mice were infused with T/HS and T/SS lymph from
different pigs. The lymph used for each mouse was collected from
an individual pig (pooled fractions collected during 1–3 hr post T/
SS or T/HS). T/HS or T/SS pig lymph was infused via the
jugular catheter at a rate of 10 mL/g body weight per hour for
3 hours. At the end of the 3 hour lymph infusion period, the mice
were euthanized. The EBD lung permeability assay was
performed and the lungs were harvested for myeloperoxidase
(MPO) levels, and western blotting. The rationale for the lymph
volume infused was based on the actual amount of lymph
produced by the pigs (ml/kg/hr) subjected to T/HS or T/SS over
the shock and resuscitation period which was approximately 28–
30 mL/kg [25]. Dose-response pilot studies of pig T/HS lymph
documented that lung injury occurred with doses of pig lymph as
low as 10 mL/g body weight (data not shown).
Evans blue dye (EBD) lung permeability assay
Mice were injected with EBD (30 mg/kg in 4% bovine serum
albumin) via the internal jugular catheter 30 min prior to the end
of the 3 hr reperfusion period following T/HS or T/SS or 30 min
prior to the end of the 3 hr lymph infusion. After 10 minutes
(allowing complete circulation of the dye), a blood sample (0.3 mL)
was withdrawn from the femoral artery catheter, centrifuged and
the resultant plasma was serially diluted to form a standard curve
for EBD. After 20 min of EBD injection, a cardiopulmonectomy
was performed after the mouse was fully exsanguinated. A
bronchoalveolar lavage was then performed on the excised lungs.
1 ml of phosphate buffered saline (PBS) was instilled, rinsed in and
out 3 times, repeated twice and the bronchoalveolar lavage fluid
(BALF) was collected, centrifuged and the absorbance of EBD
(620 nm) in the supernatant was measured spectrophotometrically.
The percentage of EBD in the BALF was determined relative to
the standard curve of EBD in the plasma.
Myeloperoxidase assay
Frozen lung tissue was homogenized and assayed for MPO
activity as previously described [2]. One unit of MPO activity
represents the amount of enzyme that will reduce 1 mol/min of
peroxide.
Western blot analysis
Whole cell extracts (WCE) prepared from lung tissue as
previously described [26] were resolved by SDS-PAGE and
detected by western blotting. The following antibodies were used:
rabbit anti-iNOS (1:3000; BD Biosciences) and rabbit anti-p42/
TLR4 Mediates Lung Injury
PLoS ONE | www.plosone.org 2 August  2011 | Volume 6 | Issue 8 | e14829p44 (1:1000, Cell Signaling). As reported by others [27], total p42/
p44 was used as our loading control since the expression of
commonly used loading controls such as actin and tubulin have
been shown to be altered in tissues of animals subjected to I/R
injury [28]. The western blots were developed with immoblin
western (Millipore) and then analyzed by densitometry using an
AlphaImager 3400 imaging system and AlphaEase FC software
(Alpha Innotech).
Measurement of endotoxin in mesenteric lymph and
endotoxin removal process
Lymph pooled from different pigs (n=4–5) collected from the
first 3 hr after T/HS were used in these assays. Endotoxin levels in
the mesenteric lymph samples were measured using the limulus
lysate assay pyrogent plus test kit according to the instructions
provided by Lonza. Each sample was heat treated at 70uC for 5
minutes to inactivate potential inhibitory factors present in the
mesenteric lymph and run in duplicate. The limit of detection was
0.06 endotoxin units (EU) /ml.
To further exclude the possibility that endotoxin is responsible
for the lung injurious effects of the T/HS lymph samples,
endotoxin removing columns containing immobilized polymyxin
B that binds and removes endotoxin (Detoxi-Gel Endotoxin
Removing Columns, Thermo Scientific Pierce) were used
according to the manufacturer’s instructions. To validate the
efficacy of the columns, PBS and lymph specimens were spiked
with 0.25 EU of endotoxin (E. coli 055:B5, Lonza) and endotoxin
levels of spiked samples were measured using the limulus assay
both prior to being placed on the column as well as after passage
through the columns. Pre- and post-polymyxin-immobilized
column eluted T/SS and T/HS lymph samples were infused in
naı ¨ve C57BL6 mice for 3 hours as described above.
Isolation and Detection of Bacterial DNA in Mesenteric
Porcine Lymph
DNA was isolated from 500 mL of porcine mesenteric lymph.
The samples were centrifuged at 20,000xg for 10 min at 4uC and
the pellet was lysed using MagNA Pure bacteria lysis buffer
according to the manufacturer’s instructions (Roche Diagnostics
GmBH). DNA was isolated using the QIAamp DNA Mini Kit
(Qiagen). DNA was also isolated from E. Coli as a positive control
for bacterial DNA. PCR reactions for the amplication of the 16S
ribosomal RNA wereperformed. The 16S rRNA primers were
synthesized in the Molecular Resource Facility (New Jersey
Medical School). The sequences of the 16S primer set included
the forward primer (59-TCCTACGGGAGGCAGCAGT-39) and
reverse primer (59-GGACTACCAGGGTATCTAATCCTGTT-
39) as described in [29]. The PCR reaction was performed with
5 ng of template and 50 pM of each primer using Platinum Taq
polymerase (Invitrogen) in a thermal cycler 2720 (Applied
Biosystems). DNA from E.coli served as a positive control and
sterile water without template served as a negative control.
Thermocycling conditions were: 95uC for 4 min, 25 cycles at 94uC
for 30 s, 58uC for 30 s and 72uC for 30 s followed by a final
extension at 72uC for 7 min. A 466 bp PCR 16S rRNA product
was visualized on an 1.5% agarose gel stained with ethidium
bromide.
Statistics
Analysis of variance (ANOVA) with the post hoc Tukey-
Kramer multiple comparison test was used for comparisons
between groups. Results are expressed as mean 6 SE. P values less
than 0.05 were considered statistically significant.
Results
Infusion of porcine mesenteric T/HS lymph induces lung
injury in naı ¨ve CD1 mice
Our earlier studies demonstrated that the infusion of rat T/HS
mesenteric lymph into naı ¨ve mice recreated the lung injury
observed with actual T/HS [4]. As reported in our in vitro studies
using T/HS lymph from rats [2], pigs [25] and baboons [3]
mesenteric lymph collected from male pigs subjected to T/HS
contributed to priming of neutrophils and endothelial dysfunction.
Thus, we first determined whether the infusion of sterile porcine
mesenteric T/HS lymph into naı ¨ve CD1 mice caused similar lung
injury as observed in CD1 mice subjected to T/HS. The rationale
for using CD1 mice is that these mice have a robust immune
system and do not have any of the potential confounding factors
associated with inbreeding. As shown in Fig. 1, the infusion of pig
T/HS lymph increased lung permeability to EBD by 2-fold as
compared to CD-1 mice infused with T/SS pig lymph. Likewise, a
2.3-fold increase in percentage of EBD in the BALF was found in
CD-1 mice subjected to actual T/HS as compared to their T/SS
counterparts.
TLR4 deficiency attenuates porcine T/HS lymph-induced
lung injury
Having documented that T/HS lymph can recreate lung injury,
we tested the hypothesis that non-microbial factors in the intestinal
mesenteric lymph after T/HS mediate gut-induced lung injury via
TLR4 activation. WT and TLR4
mut mice were infused with
porcine T/SS or T/HS lymph for 3 hours. Infusion of WT mice
with T/HS lymph increased lung permeability by 2.5-fold as
compared to mice infused with T/SS lymph (Fig. 2A). In contrast,
there was no significant increase in lung permeability in TLR4
deficient mice infused with T/HS lymph relative to their T/SS
lymph infused counterparts. Since the sequestration of polymor-
phonuclear neutrophils (PMNs) into the lung microvasculature
has been characterized as a hallmark of ALI, MPO levels were
measured in lung homogenates. As shown in Fig. 2B, a modest
increase in MPO activity was evident in WT mice infused with
Figure 1. Pig T/HS lymph infusion in naı ¨ve CD1 mice recreates
T/HS-induced lung injury. Lung permeability to Evans Blue dye
(EBD) was measured in CD-1 mice subjected to actual T/HS or T/SS for
60 min and 3 hr reperfusion as well as CD1 mice infused with porcine T/
SS or T/HS lymph for 3 hr. Data expressed as mean 6 SE (n=5–6 mice/
group).
doi:10.1371/journal.pone.0014829.g001
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There was no difference between MPO levels in TLR4
mut
mice infused with T/HS or T/SS lymph. These findings suggest
that factors in T/HS lymph mediate lung injury via TLR4
activation.
Since TLR4 mediates its downstream effects via two distinct
signaling pathways, Myd88 and TRIF, we determined the effects
of Myd88 and TRIF deficiency on T/HS lymph-induced lung
injury. In both WT and Myd88
2/2 mice, infusion with T/HS
lymph increased lung permeability by 3.3-fold (p,0.001) and 1.5-
fold (p,0.01) respectively versus their T/SS lymph infused
counterparts (Fig. 3A). The baseline level of lung permeability
for the T/SS lymph infused Myd88
2/2 group was approximately
1.8-fold higher than the WT T/SS lymph infused group (p,0.05).
In contrast, there was no significant increase in the percentage of
EBD in the BALF of TRIF
mut mice infused with T/HS lymph
relative to their T/SS lymph infused group (Fig. 3B). Although
both TRIF and Myd88 deficiency attenuated T/HS lymph-
induced lung permeability (p,0.001 and p,0.05 respectively vs
WT T/HS lymph infused mice), our results suggest that TRIF
plays a more predominant role in T/HS lymph-induced lung
permeability.
To further confirm the specificity of the TLR4 response in T/
HS lymph-induced lung injury, we examined the effects of TLR2
deficiency on lung injury. In both the WT and TLR2 deficient
mice, infusion with T/HS lymph increased lung permeability and
pulmonary leukosequestration, as determined by EBD permeabil-
ity (Fig. 4A) and MPO levels (Fig. 4B).
TLR4 deficiency blunts the pulmonary iNOS response
associated with T/HS lymph-induced lung injury
Since increased iNOS activity has been implicated in T/HS-
induced lung injury [4] and iNOS is a downstream target of TLR4
activation [21], we examined the effects of TLR4 deficiency on the
pulmonary iNOS response after T/HS lymph infusion. Compared
with WT mice infused with T/SS lymph, iNOS protein levels
were 3-fold higher in WT mice infused with T/HS lymph (Fig. 5A
and B). The induction of iNOS expression in lung homogenates
from TLR4
mut mice infused with T/HS lymph was markedly
reduced as compared to their WT counterparts but remained
elevated as compared to TLR4
mut mice infused with T/SS lymph.
Lungs from WT and TLR4
mut mice infused with T/SS lymph
expressed negligible levels of iNOS protein. These findings suggest
an association between the T/HS lymph-induced pulmonary
iNOS response and TLR4 activation.
Endotoxin-and bacterial DNA- independent factors in
T/HS lymph mediate lung injury
Although the lymph samples tested had no bacterial growth and
were sterile (data not shown), we needed to rule out the possibility
that the activation of TLR4 by T/HS lymph was due to gut-
derived endotoxin contamination. Using a limulus lysate assay,
Figure 2. TLR4 deficiency attenuates T/HS lymph infused lung injury. WT and TLR4
mut mice were infused with porcine T/SS and T/HS lymph
for 3 hr. A) Lung permeability to EBD was performed. Data expressed as mean 6 SE (n=3–12 mice/ group). B) MPO levels (U/g) were measured in
lung homogenates. Data expressed as mean 6 SE (n=4–7 mice/group).
doi:10.1371/journal.pone.0014829.g002
Figure 3. TRIF and Myd88 deficiency confer full and partial protection against T/HS lymph induced microvascular permeability. A)
WT and Myd88
2/2 and B) WT and TRIF
mut mice were infused with porcine T/SS and T/HS lymph for 3 hr and lung permeability to EBD was performed.
Data expressed as mean 6 SE (n=5–8 mice/ group).
doi:10.1371/journal.pone.0014829.g003
TLR4 Mediates Lung Injury
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levels of endotoxin by the limulus lysate assay (level of detection
0.06 EU/ml). To exclude the possibility that inhibitory factors in
the lymph samples were interfering with the limulus assay, known
quantities of endotoxin (0.06 EU, 0.125 EU or 0.25 EU) were
added to T/SS and T/HS lymph samples and then assayed for
endotoxin levels. The limulus assay tested positive for all the LPS
concentrations tested, including 0.06 EU/ml of endotoxin,
Figure 4. TLR2 does not mediate T/HS lymph-induced lung injury. WT and TLR2
2/2 mice infused with porcine T/HS and T/SS lymph for 3 hr.
A) Lung permeability to EBD was performed. Data expressed as mean 6 SE (n=4–6 mice/ group). B) MPO levels (U/g) were measured in lung
homogenates. Data expressed as mean 6 SE (n=5–6 mice/group).
doi:10.1371/journal.pone.0014829.g004
Figure 5. TLR4 deficiency reduces T/HS lymph induced pulmonary iNOS protein levels. A) and B) Western blot of iNOS in lung WCEs of WT
and TLR4
mut mice infused with porcine T/SS and T/HS lymph for 3 hr. B) Densitometry was performed to quantify iNOS and total p42/p44 MAPK
expression. Data expressed as mean 6 SE (n=4–7 mice/group).
doi:10.1371/journal.pone.0014829.g005
TLR4 Mediates Lung Injury
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endotoxin present in the lymph samples (data not shown). To
further confirm that factors in T/HS lymph that mediate lung
injury and activate TLR4 are devoid of endotoxin, pre- and post-
polymyxin-immobilized column eluted T/SS and T/HS lymph
samples were infused in naı ¨ve C57BL6 mice for 3 hours. As shown
in Figure 6A, the magnitude of lung permeability was similar in
mice infused with pre- and post-column T/HS lymph samples as
compared to mice infused with T/SS lymph samples. Additionally,
PCR analysis was performed to detect bacterial DNA in T/SS and
T/HS lymph using a primer set which specifically detects 16S
rDNA of the Domain Bacteria [29] and neither T/HS nor T/SS
lymph tested positive for bacterial DNA contamination (Fig. 6B).
Discussion
Studies investigating the pathophysiology of trauma-induced
SIRS, ARDS and multiple organ dysfunction syndrome (MODS)
have been a major area of investigation. Work by us [1,2,3,30] and
others [31,32,33,34,35] have demonstrated that splanchnic
ischemia leading to gut inflammation and loss of barrier function
is the initial triggering event that turns the gut into the ‘motor of
MODS’. Although, it was originally proposed that bacterial
(endotoxin) translocation was the link between gut and distant
organ injury, most recently, using rodent [36], porcine [24], and
non-human primate trauma-hemorrhagic shock [3] as well as
burn models [37], we have documented that acute ARDS and
MODS observed after a major injury is due to immuno-
inflammatory, tissue-injurious factors exiting the gut via the
intestinal lymphatics. More support for the gut-lymph hypothesis
of MODS stems from our recent study demonstrating that naı ¨ve
rats and mice infused with mesenteric lymph from rats subjected to
T/HS develop ALI [4]. Our current study extends these results by
showing that T/HS lymph-induced lung injury occurs via a
TLR4-dependent pathway. The notion that TLR4, as well as
other pattern recognition receptors, can respond to non-bacterial
endogenous danger-type molecules as well as microbial products
has expanded the role of pattern recognition receptors beyond that
of sensors of microbial invasion [38]. This concept also helps
explain the many similarities between the host’s septic response
and the augmented inflammatory response to shock-trauma and
other forms of major tissue injury.
Our results implicating TLR4, but not TLR2, as the proximal
receptor for T/HS lymph-induced lung injury is novel in that we
have implicated non-bacterial factors in mesenteric lymph that are
able to directly activate TLR4. These findings are consistent with
other studies showing that hemorrhagic shock-induced lung injury
[16], and liver injury [13,18] is reduced in TLR4 deficient mice
but not TLR2 deficient mice. Since other non-infectious models of
injury, such as femur fracture [18,39] and thermal injury [20] also
document that TLR4 deficient animals are protected, it appears
that this immune-activating and tissue-injurious effect of TLR4
may be a common response to diverse shock and tissue-injury
states. On the other hand, in certain conditions, such as hyperoxia-
induced lung injury, TLR4 activation has been shown to be
protective [40,41]. Thus, like many other systems, whether TLR4
activation is protective or deleterious may depend on the condition
being studied as well as the timing and magnitude of its activation.
Nonetheless, it is now clear that during tissue injury or proteolysis,
extracellular matrix components undergo cleavage, exposing
moieties that can act as ligands for TLRs and thereby initiate
TLR-induced signal transduction. In this way, innate immune
inflammatory responses may be activated without the presence of
invading bacteria, but rather as a direct consequence of tissue
injury [21].
Depending on the type, magnitude and duration of insult as well
as the site of injury, the specificity of the TLR4 response is
determined by the selective recruitment of its adapters, namely
Myd88/TIRAP and TRIF/TRAM and their respective down-
stream signaling. Although there have been extensive studies
delineating the Myd88-dependent and TRIF-dependent intracel-
lular signaling pathways in the pulmonary innate immune
response to microbial infections, our knowledge of their down-
stream signaling cascades in models of sterile/noninfectious ALI is
very limited. For example, HMGB1/TLR4/Myd88 signaling
activates NAD(P)H oxidase in neutrophils after hemorrhagic shock
[42] whereas oxidized phospholipids mediate acid-induced ALI
via TRIF signaling [43]. Our study shows full and partial
protection against T/HS lymph induced microvascular damage
in TRIF and Myd88 deficient mice respectively. However, more
work must be done to determine whether TRIF activation plays a
more predominant role in the lung injurious effects of T/HS
lymph than Myd88 activation.
Among the cells that bear TLR4 are those of the innate immune
system, including macrophages, neutrophils and dendritic cells [9].
Since TLR4 activated inflammatory cells manifest increased nitric
oxide production [44,45], we asked whether TLR4 activation in
T/HS lymph-induced lung injury was associated with the
induction of the iNOS response. Our findings demonstrated that
lung iNOS expression was markedly but not completely reduced in
TLR4
mut mice infused with T/HS lymph as compared to iNOS
Figure 6. Endotoxin- and bacterial DNA-independent factors in
T/HS lymph mediate lung injury. A) Pre- and post-polymyxin-
immobilized column eluted T/SS and T/HS lymph samples were infused
in naı ¨ve C57BL6 mice for 3 hours. Lung permeability to EBD. Data
expressed as mean 6 SE (n=3–9 mice/ group). B) DNA isolated from
lymph pooled from 3 pigs subjected to either T/HS or T/SS lymph was
tested for bacterial DNA contaminants by PCR using 16S rDNA primers.
DNA isolated from E.Coli served as our positive control was depicted as
+ and the negative control containing no DNA template was depicted
as -. M denotes a 100 bp size marker.
doi:10.1371/journal.pone.0014829.g006
TLR4 Mediates Lung Injury
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the induction of the iNOS response by T/HS lymph is modulated
by both TLR4-dependent and TLR4-independent pathways, the
concept that up-regulated iNOS activity is involved in the
pathogenesis of T/HS-induced lung injury is consistent with
studies showing that excessive nitric oxide production contributes
to trauma-shock-induced organ injury [46,47,48,49]. Thus, taken
together, our previous work showing iNOS deficient mice are
resistant to T/HS lymph-induced lung injury [4] and the current
study documenting that TLR4 deficient mice are also resistant to
T/HS lymph-induced lung injury provide important clues as to
how T/HS is converted from a hemodynamic insult into an
inflammatory and lung tissue injurious disease.
Having demonstrated that T/HS lymph is capable of recreating
shock-induced lung injury through TLR4- and iNOS-dependent
pathways, the question arises about the composition of T/HS
lymph and what factors within it are triggering this response.
Although T/HS lymph is collected from animals subjected to T/
HS, in which gut barrier function is impaired, we do not believe
that intestinal bacteria and/or endotoxin are responsible for the
biologic activity of T/HS lymph. This conclusion is based on our
current results showing that the pig lymph samples were devoid of
bacteria, bacterial DNA and did not contain measurable levels of
endotoxin. Furthermore, the biologic lung-injurious activity was
not abrogated after passage through an endotoxin removal
column. The notion that injury-induced TLR4 activation is not
due to endotoxin is also supported by studies showing that TLR4
deficient but not CD14 deficient mice were resistant to liver injury
after major trauma [18]. Additionally, if gut-derived bacterial
products in T/HS lymph are involved in lymph-induced lung
injury, gram-positive (peptidoglycan) as well as gram-negative
(endotoxin) bacterial products would be present in T/HS lymph.
Since peptidoglycan activates TLR2 and TLR2
2/2 mice are not
resistant to T/HS lymph-induced lung injury, it is not likely that
gram-positive microbial factors were responsible for the lung-
injurious effects of T/HS lymph. The fact that TLR4 has the
capacity to recognize and respond to endogenous ligands is also
consistent with recent observations showing that T/HS contains
several incompletely identified and biologically-active non-cyto-
kine protein and lipid factors [6,7,8] including a modified albumin
species [7]. Thus, we believe that T/HS lymph contains modified
proteins and lipids which could either act as endogenous TLR4
ligands or promote the release of danger signals from a stressed or
activated cell population within the lung. Regardless of whether
factors in the mesenteric T/HS lymph are acting directly or
indirectly in the induction of the TLR4 response, our findings
demonstrate that these factors play a role in the sterile
inflammatory process that occurs after trauma-hemorrhage.
One advantage of the T/HS lymph infusion model is that it
provides a unique opportunity to study the effects of shock-
induced, gut-derived factors in vivo without the confounding
systemic effects of trauma and hemorrhagic shock. Since T/HS
lymph is produced in vivo and the amounts of lymph required to
cause lung injury were equal to or less than what would be
produced during the actual trauma-shock period, speaks to the
physiologic relevance of the model. Furthermore, since both rat
and pig T/HS lymph cause lung injury in mice, a cross-species
event, it appears that the factor or factors within T/HS lymph
may be conserved among different species and likely target the
same pattern recognition receptors. This cross species observation
is also important since pigs are physiologically closer to humans
than rodents. Taken together, these results lend further support for
the Danger model of immune activation, which states that our
immune system is not only activated by foreign pathogens, but also
by our own endogenous ligands, whose patterns are evolutionarily
preserved [50].
In summary, our studies suggest that TLR4 activation by T/HS
lymph is necessary for T/HS lymph-induced lung injury and an
augmented pulmonary iNOS response. More importantly, our
results suggest that non-bacterial factors in T/HS mesenteric
lymph mediate cross talk between tissue injury in the gut and
subsequent gut-induced lung injury. Future studies elucidating the
contribution of TLR4 and its downstream signaling in both
immune and parenchymal cell populations that mediate T/HS
lymph-induced lung injury as well as identifying endogenous
TLR4 ligands after T/HS will provide more insight in the
pathogenesis of shock-induced ALI and identify potential
therapeutic targets.
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